Australia markets closed

Avalo Therapeutics, Inc. (AVTX)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
11.73-1.52 (-11.47%)
At close: 04:00PM EDT
12.03 +0.30 (+2.56%)
After hours: 07:19PM EDT
Currency in USD
Earnings estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts1111
Avg. Estimate-1.18-0.19-0.91-0.97
Low estimate-1.18-0.19-0.91-0.97
High estimate-1.18-0.19-0.91-0.97
Year ago EPS-204-141.6-114-0.91
Revenue estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts1111
Avg. EstimateN/AN/AN/AN/A
Low estimateN/AN/AN/AN/A
High estimateN/AN/AN/AN/A
Year ago sales475k643k1.92MN/A
Sales growth (year/est)N/AN/AN/AN/A
Earnings history30/03/202329/06/202329/09/202330/12/2023
Est. EPS-232.8-192-264-4.8
Actual EPS-204-141.6-26.4-116.21
Difference28.850.4237.6-111.41
Surprise %12.40%26.20%90.00%-2,321.00%
EPS trendCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Current estimate-1.18-0.19-0.91-0.97
7 days ago-1.18-0.19-0.91-0.97
30 days ago-4.8-4.8-16.8-16.8
60 days ago-4.8-4.8-16.8-16.8
90 days ago-4.8-4.8-16.8-16.8
EPS revisionsCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Up last 7 daysN/AN/AN/AN/A
Up last 30 days1111
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesAVTXIndustrySector(s)S&P 500
Current qtr.99.40%N/AN/AN/A
Next qtr.99.90%N/AN/AN/A
Current year99.20%N/AN/AN/A
Next year-6.60%N/AN/AN/A
Next 5 years (per annum)N/AN/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A